CPX-351 for higher risk myelodysplastic syndrome: cytarabine and daunorubicin in disguise?
The Lancet Haematology(2023)
Key words
higher risk myelodysplastic syndrome,daunorubicin,cytarabine
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined